Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot/Phase 1, Interventional, Open-label, Multi-center Study to Assess the Safety and Efficacy of L-glutamine Treatment in Patients With Diverticulosis

NCT05106101 is registered in ClinicalTrials.gov with Emmaus Medical, Inc. as lead sponsor.

NCT NCT05106101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05106101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot/Phase 1, Interventional, Open-label, Multi-center Study to Assess the Safety and Efficacy of L-glutamine Treatment in Patients With Diverticulosis
Lead sponsor
Emmaus Medical, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 19, 2019
Completion date
December 30, 2022
Enrollment
9 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diverticulosis, colonic